Iambic Therapeutics | Better technology for better medicines

Better technology for better medicines

Our molecular superintelligence platform delivers highly differentiated drug candidates, optimized for patient and partner impact

Optimized medicines for optimized profiles

Our AI technologies, Enchant and NeuralPLexer, drive a high-throughput experimental platform that converts novel molecular designs into biological insights each week

Platform

Innovation

Multimodal transformer and co-folding AI technologies built for the purpose of drug discovery

Automation

AI-driven, high-throughput experimentation to go from new molecular designs to new biological data each week

Execution

A proprietary pipeline of differentiated clinical candidates delivered at a pace years faster than the industry standard

Platform-driven pipeline of highly differentiated drug programs

Sumo quo nihil et. Quidem dolor aliquam est vero qui labore aperiam iusto ex facilis magnam doloribus ut. Fugiat neque sunt aliquid aliquid quia culpa est sequi qui repellat quam et.

Pipeline

IAM1363 for HER2

Phase 1/1b

Multimodal transformer and co-folding AI technologies built for the purpose of drug discovery

IAM217 for KIF18A

IND-enabling

Highly differentiated, brain-penetrant inhibitor for ovarian cancer, triple-negative breast cancer, and other solid tumor cancers

IAM-C1 for CDK2/4

IND-enabling

Highly selective CDK2/4 small-molecule inhibitor for HR+/HER2- metastatic breast cancer

Innovation through the collaboration of AI experts and drug hunters

By placing AI innovations in the hands of our seasoned drug hunters, we’re optimizing our path towards differentiated therapeutics

About us